When Governance Kills

She was seven months old. Her name was Fatima.

Her mother carried her for two hours by rickshaw through the crushing Dhaka heat. The nearest clinic had run out of the measles vaccine three weeks earlier. The nurse had said, “Come back next month.” But by next month, Fatima had a fever, then a rash, followed by the cough that wouldn’t stop.
She died on a Wednesday night. The paediatric ward had no oxygen left. A doctor held her hand in remorse, not because he didn’t know how to treat measles, but because he had no vaccine to give her three months ago, and no ICU bed to save her now.

Fatima is not a statistic. She is one of more than 300 children who have perished in Bangladesh’s current measles outbreak, an outbreak that has swept across 58 of the country’s 64 districts, hospitalised over 50,000 children, and, on the single deadliest day, 4th May, claimed 17 young lives in 24 hours.

Here is what makes Fatima’s death unforgivable. Measles has been entirely preventable for over sixty years. We have the vaccine. We know the schedule. We have global financing. And Bangladesh, until very recently, was celebrated as a model of universal immunisation success.

How did a story of success turn into a heartbreaking tragedy with so many children affected? It wasn’t because the virus suddenly became more powerful. Instead, it was a series of human choices—many of which could have been avoided and were even warned against—that transformed a fragile health system into a devastating crisis.

This is not a natural disaster; it is a failure of governance, attributable to those who have perished.

Let us examine how progress unraveled.

For years, Bangladesh followed a proven formula: two routine doses of measles‑rubella vaccine at 9 months and 15 months, supplemented by nationwide campaigns every four years to reach the 95% coverage threshold needed to prevent outbreaks. UNICEF supplied the vaccines, with most funding from GAVI and government contributions. Between 2000 and 2016, first‑dose coverage soared. After 2012, second‑dose coverage followed. The country stood on the brink of measles elimination.

Then came the political turbulence of 2024. The immediate trigger was a wrong procurement decision. In September 2025, the Muhammad Yunus-led interim government halted vaccine procurement through UNICEF and switched to an open-tender system. Bureaucracy slowed down the new process, causing vaccine supplies to run out. This led to nationwide shortages that affected routine immunisation. The supplementary MR campaign, initially planned for 2024, was first postponed and then canceled altogether due to political unrest.

UNICEF had sounded the alarm loudly and repeatedly. “It was very frustrating,” said Rana Flowers, UNICEF’s representative in Bangladesh. “We warned them directly.” Those warnings went unheeded.

The result was catastrophic. Routine vaccine coverage fell to just 59%, a far cry from the 95% herd immunity needed to halt transmission. Measles tore into that gap with devastating speed.

There were deeper weaknesses that turned an outbreak into a calamity. It would be convenient to call this a simple supply chain failure. Experts reject that framing. “Beyond immunisation gaps, Bangladesh’s measles crisis reflects deep structural weaknesses,” said Mohammad Mushtuq Husain, adviser at the Institute of Epidemiology, Disease Control and Research (IEDCR).

Malnutrition is rampant. About 28% of children under five are stunted; 10% suffer from wasting. Vitamin A deficiency further weakens children’s defences, and Bangladesh has missed three consecutive biannual vitamin A distribution campaigns since 2024.

Chronic underinvestment in public health infrastructure meant that poorly funded clinics were overwhelmed within days. The military was eventually called in to erect field hospitals.

Mahmudur Rahman, chief of the National Verification Committee on Measles and Rubella, admitted plainly: “We committed to reducing the number to zero by December 2025 but failed to achieve the target due to poor vaccination programmes.”

Tajul Islam A. Bari, a former Expanded Programme on Immunisation official, was equally direct. Funds had been allocated for vaccine purchases, he said, but authorities had failed to actually procure them. “Now we see the result. The situation is scary.”

Five Lessons Bangladesh Cannot Afford to Ignore

If Fatima’s death is to have any meaning, these lessons must be carved into national policy, not merely debated, then forgotten when the next news cycle arrives.

Firstly and most importantly, Immunisation systems must be insulated from political turbulence. Vaccines are not a policy preference to be renegotiated with each change of government. They are a standing obligation to children who have no vote and no recourse. The absence of regular nationwide supplementary MR campaigns since 2020, combined with the 2024–2025 vaccine stock-out, has created a generation of susceptible children. Any future procurement reform must include non-negotiable continuity clauses and automatic triggers for WHO and UNICEF involvement if supply chains are disrupted.

Secondly, establishing a standing public health emergency fund with a dedicated immunisation reserve. The current crisis required frantic scrambling to international partners for emergency support, a reactive posture that cost precious lives. A proactive system would have pre-positioned vaccines, maintained real-time district-level coverage dashboards, and triggered automatic catch-up campaigns whenever coverage dipped below a defined threshold. This fund must be shielded from budget reallocation and political interference.

Third and most critical, treat nutrition and vaccination as inseparable. The high case fatality rate in this outbreak is directly linked to malnutrition, which severely compromises children’s immune response. Vitamin A supplementation, growth monitoring, and routine immunisation should be delivered together at the community level, not as siloed programmes that can be disrupted separately. A malnourished child who receives the vaccine is still at risk; a well‑nourished child who misses the vaccine is also at risk. Both gaps must be closed simultaneously.

Fourth, strengthening surveillance to detect immunity gaps before outbreaks occur.

Bangladesh’s current surveillance infrastructure is reactive – it finds cases only after the virus is already spreading. An early warning system that uses school enrolment data, serological surveys (sero-surveys), and community health worker reports could flag dangerously low coverage in specific upazilas months before a single case is confirmed. The current outbreak represents a reversal of previous progress towards measles elimination. That reversal must be visible on a dashboard before it becomes visible in a morgue.

Finally, it’s important to focus on removing political influence from the health system at the operational level to ensure it functions more effectively and fairly.

Benazir Ahmed, former director of disease control at the Directorate General of Health Services, warned that emergency vaccination campaigns are unlikely to quickly stop an epidemic, given the speed of measles transmission. Emergency responses are no substitute for a system that never allows coverage to collapse in the first place. That means removing procurement, staffing, and campaign planning from the cycle of political reward and punishment. Health officials must be empowered to act on evidence, not on the shifting priorities of whichever government holds power.

Bangladesh has recorded more than 336 child deaths since mid-March. Behind every number is a family whose child did not have to die. Measles is not a mystery. It is not uncontrollable. It is entirely preventable with tools that exist, supply chains that can be maintained, and governance structures that can be designed to outlast any single political moment.

The Bangladesh government now faces a real choice. It can see this outbreak as a temporary problem caused by unusual circumstances and return to normal once the immediate issues are resolved. Or, it can recognise it as a sign of deeper systemic issues and take the opportunity to build a strong, proactive, and well-protected public health system that Bangladeshi children have been waiting for but haven’t consistently had.

The names of those 300 children are an argument for the second path. So is every child who will be born in Bangladesh tomorrow. And so is Fatima.